Search this site:

Vol. 26, No.6
June  2003


Endocarditis Prophylaxis Yes: Endocarditis Prophylaxis No

C. R. Conti, M.D., M.A.C.C. 255

The Failing Heart and the Hemodynamic Response to Vasodilator Therapy

R. M. Mills, M.D. 257


Cholesterol Absorption Inhibitors: Defining New Options in Lipid Management

W. V. Brown, M.D. 259

Clinical Investigations

Clinical and Angiographic Follow-Up after Long versus Short Stenting in Unselected Chronic Coronary Occlusions

S.-W. Choi, M.D., C. W. Lee, M.D., M.-K. Hong, M.D., J.-H. Lee, M.D., J.-J. Kim, M.D., Ph.D., S.-W. Park, M.D., Ph.D., S.-J. Park, M.D., Ph.D. 265

Secondary Prognosis after Cardioembolic Stroke of Atrial Origin: The Role of Left Atrial and Left Atrial Appendage Dysfunction

K. Panagiotopoulos, M.D., S. Toumanidis, M.D., K. Vemmos, M.D., N. Saridakis, M.D., S. Stamatelopoulos, M.D. 269

Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy: Short-Term Results in 50 Consecutive Procedures

C. D. Nielsen, M.D., D. Killip, R.N., W. H. Spencer III, M.D. 275

Patients with Large Myocardial Infarction Gain a Greater Improvement in Exercise Capacity after Exercise Training than Those with Small to Medium Infarction

S. Sakuragi, M.D., S. Takagi, M.D., S. Suzuki, M.D., F. Sakamaki, M.D., H. Takaki, M.D., N. Aihara, M.D., Y. Yasumura, M.D., Y. Goto, M.D. 280

Exercise Capability and Myocardial Perfusion in Chronic Angina Patients Treated with Enhanced External Counterpulsation

J. Tartaglia, M.D., J. Stenerson, Jr., M.D., R. Charney, M.D., S. Ramasamy, M.D., B. L. Fleishman, M.D., P. Gerardi, M.D., J. C. K. Hui, Ph.D. 287

Images in Cardiology

Shooting Stars in the Ventricle: 2-D Color Doppler Echocardiographic Findings of Coronary Cameral Fistula

B.K. Singh, M.D., I.E. Fahdi, M.D., C.V. Kishan, M.D., J.L. Mehta, M.D., Ph.D. 286


QT-Interval Dispersion in Acute Myocardial Infarction Is Only Shortened by Thrombolysis in Myocardial Infarction Grade 2/3 Reperfusion

S. Nikiforos, M.D., J. Hatzisavvas, M.D., G. Pavlides, M.D., V. Voudris, M.D., V. P. Vassilikos, M.D., A. Manginas, M.D., G. Hatzeioakim, M.D., S. Foussas, M.D., E. K. Iliodromitis, M.D., D. Hatseras, M.D., D. T. Kremastinos, M.D., D. V. Cokkinos, M.D. 291

Progress in Clinical Trials

ARCHeR (Acculinkª for Revascularization of Carotids in High-Risk Patients) 296
COMPANION (Comparison of Medical Therapy, Pacing, and Defibrillation) 296
EPHESUS (Eplerenone Post-AMI Heart Failure Efficacy and Survival Trial) 297
FACIT II (Folate After Coronary Intervention) 297
SIRIUS (Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de novo Coronary Artery Lesions) Cost-Effectiveness 298
SPORTIF-III (Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Nonvalvular Atrial Fibrillation) 298
TAXUS II (Paclitaxel-Eluting Stent 12-Month Follow-up) 298
TWA in CHF (T-Wave Alternans in Congestive Heart Failure) 299

Profiles in Cardiology

Velva Schrire

P. Commerford, M.D., and L. Vogelpoel, M.D. 300

Continuing Medical Education

Articles in Brief A20

Letters to the Editor A26

©1997-2002 Foundation for Advances in Medicine and Science